ETX — E-Therapeutics Share News
0.000.00%
Last trade - 00:00- £54.93m
- £23.53m
- £0.48m
Notice to Shareholders - AGM Virtual Access
Brief: E-Therapeutics Announces Director Dealing, Issue Of Equity
Director Dealing and Issue of Equity
Notice of AGM and Posting of Annual Report
Brief: E-Therapeutics Posts FY Loss After Tax Of £8.1 Mln
Final results for the year ended 31 January 2022
Notification of Full Year Results Date
Key Milestone Achieved on Galapagos Collaboration
Brief: E-Therapeutics Announces Immuno-Oncology Research Collaboration With Iteos
Immuno-Oncology Research Collaboration with iTeos
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Total Voting Rights
New Corporate Website
Holding(s) in Company
Director Dealing and Issue of Equity
Brief: E-Therapeutics Says Karl Keegan Will Step Down From His Role As CFO
Senior Management Update